Nepal Healthcare Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Nepal Healthcare Times.

Press releases published on October 5, 2026

Oct. 5, 2026

Alector Enters Global License Agreement with Genentech for Brain Penetrant GCase Enzyme Replacement Therapy for Parkinson’s Disease and Other Neurodegenerative Diseases

Indeterminate GlobeNewswire

Oct. 5, 2026

Harrow Closes Acquisition of TYRVAYA®

Indeterminate GlobeNewswire

Oct. 5, 2026

Rezolute Announces FDA Recommendation to Hold a Pre-BLA Meeting as a Precursor to Submitting a Biologics License Application (BLA) for Congenital Hyperinsulinism

Indeterminate GlobeNewswire

Oct. 5, 2026

New Pico Laser for Tattoo Removal Includes Installation, On-Site Training and a Two-Year Warranty That Covers Technician Travel

Indeterminate GlobeNewswire

Oct. 5, 2026

Real-World Analysis Highlighting HAE Disease Experience and Gaps in Treatment Satisfaction Published in Advances in Therapy

Indeterminate GlobeNewswire

Oct. 5, 2026

Fortrea Announces Date for Third Quarter 2026 Financial Results and Conference Call

Indeterminate GlobeNewswire

Oct. 5, 2026

Your Postal Code Shouldn’t Determine Your COPD Care. In Canada, It Still Does.

Indeterminate GlobeNewswire

Oct. 5, 2026

Vaxcyte Reports Positive Topline Data from OPUS-1, the Pivotal Adult Phase 3 Trial of VAX-31, the Company’s 31-Valent Pneumococcal Conjugate Vaccine Candidate

Indeterminate GlobeNewswire

Oct. 5, 2026

Digbi Health Study of Nearly 16,000 Members Finds Precision Biology GI Care Delivers IBS Relief at Scale

Indeterminate GlobeNewswire

Oct. 5, 2026

Flyte Aviation Launches Under NYSE American Ticker “VJET”

Indeterminate GlobeNewswire

Oct. 5, 2026

FDA approves additional U.S. manufacturing capacity for SIMLANDI®, Alvotech’s biosimilar to Humira®

Indeterminate GlobeNewswire

Oct. 5, 2026

Aravax to Communicate Results of its Phase 2 Clinical Trial of PVX108, a Novel immunotherapy for the Treatment of Peanut Allergy, at Major Scientific Meetings in November 2026

Indeterminate GlobeNewswire

Oct. 5, 2026

Averly Health launches to transform cardiometabolic care in the UK

Indeterminate GlobeNewswire

Oct. 5, 2026

Elevate Holistics Launches Telehealth Platform for At-Home, Low-Dose Ketamine Care

Indeterminate GlobeNewswire